NCT05655546View on ClinicalTrials.gov

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

NATerminatedINTERVENTIONAL
Enrollment

2,117

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
ImmunodeficiencyImmunosuppressionHIV InfectionsGraft Versus Host DiseaseLeukemiaLymphomaCancerMultiple MyelomaTransplantAge-Related Immunodeficiency
Interventions
OTHER

Access to Cue Health COVID-19 Remote testing and treatment for COVID-19

Participants will receive at home COVID-19 test for themselves and others in their household.

Trial Locations (1)

92037

Scripps Research, La Jolla

Sponsors

Collaborators (1)

Cue Health
All Listed Sponsors
collaborator

Cue Health

UNKNOWN

lead

Scripps Translational Science Institute

OTHER

NCT05655546 - ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals | Biotech Hunter | Biotech Hunter